Neoadjuvant Hormonal Therapy On Seminal Vesicles Reduction: Optimal Clinical Target Volume For The Seminal Vesicles In Localized Prostate Cancer Radiation Therapy
xiangye qi,xiqi gao,fei li,hao li,bo zhao,dong wang
DOI: https://doi.org/10.1016/j.ijrobp.2014.05.1376
2014-01-01
Abstract:Purpose/Objective(s)Neo-adjuvant hormonal therapy (NHT) has nowadays been commonly administered to prostate cancer patients before receiving radiation therapy. Several studies have indicated that length and volume of the seminal vesicles (SVs) would reduce after receiving NHT. However, so far there is no detailed study concerning this issue. In this study, we performed a detailed analysis of the MR images both before and after NHT of the same group of patients, in order to determine the morphological alteration of the SVs and the MR detectable invasions within, and to see whether the SV segment included within the CTV could be reduced in intermediate- and high-risk patients.Materials/MethodsMR images (including a 3-dimension sequence) both prior and after NHT of 31 patients with localized or locally advanced prostate cancer were retrospectively reviewed. Image process as well as analysis were accomplished by the collaboration of one radiologist and one radiation oncologist. Long axis of the SV was located on a reconstructed oblique coronary plane containing both the starting and ending point of the SV. It was determined by drawing a curve connecting both endings along the center line of the SV contour in this plane. Volume of the SV and the MR detectable invasion was defined as the product of the total area in all slices and the slice thickness.ResultsVolume of SV showed an evident reduction after a median of 5 months’ NHT (median: 39.9%, range: 9.4%-66.2%). The median shortening rate of the SV length was 12.1% (range: 4.0%-28.0%). Factors associated with a higher shortening rate include clinical T3b-T4 stage, locally advanced tumor, and MRI detectable invasion. For SVs with and without MR detectable invasions, the length shortening was 16.7±4.8% and 11.1±4.4% (P<0.001); for the 12 invaded SVs and the invasions within, the volume reduction was 41.0±16.0% and 66.3±14.4% (P<0.001), both indicating that reduction rate of the invaded portion was higher or at least not lower than that of the normal portion of the SV.ConclusionsAfter a certain period of NHT, both the SVs and tumor invasions within could reduce a lot. We also found that the invaded portion reduced more than the normal portion of the SV, which indicates that the microscopic invasion would reduce more than normal SV tissue and the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. Purpose/Objective(s)Neo-adjuvant hormonal therapy (NHT) has nowadays been commonly administered to prostate cancer patients before receiving radiation therapy. Several studies have indicated that length and volume of the seminal vesicles (SVs) would reduce after receiving NHT. However, so far there is no detailed study concerning this issue. In this study, we performed a detailed analysis of the MR images both before and after NHT of the same group of patients, in order to determine the morphological alteration of the SVs and the MR detectable invasions within, and to see whether the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. Neo-adjuvant hormonal therapy (NHT) has nowadays been commonly administered to prostate cancer patients before receiving radiation therapy. Several studies have indicated that length and volume of the seminal vesicles (SVs) would reduce after receiving NHT. However, so far there is no detailed study concerning this issue. In this study, we performed a detailed analysis of the MR images both before and after NHT of the same group of patients, in order to determine the morphological alteration of the SVs and the MR detectable invasions within, and to see whether the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. Materials/MethodsMR images (including a 3-dimension sequence) both prior and after NHT of 31 patients with localized or locally advanced prostate cancer were retrospectively reviewed. Image process as well as analysis were accomplished by the collaboration of one radiologist and one radiation oncologist. Long axis of the SV was located on a reconstructed oblique coronary plane containing both the starting and ending point of the SV. It was determined by drawing a curve connecting both endings along the center line of the SV contour in this plane. Volume of the SV and the MR detectable invasion was defined as the product of the total area in all slices and the slice thickness. MR images (including a 3-dimension sequence) both prior and after NHT of 31 patients with localized or locally advanced prostate cancer were retrospectively reviewed. Image process as well as analysis were accomplished by the collaboration of one radiologist and one radiation oncologist. Long axis of the SV was located on a reconstructed oblique coronary plane containing both the starting and ending point of the SV. It was determined by drawing a curve connecting both endings along the center line of the SV contour in this plane. Volume of the SV and the MR detectable invasion was defined as the product of the total area in all slices and the slice thickness. ResultsVolume of SV showed an evident reduction after a median of 5 months’ NHT (median: 39.9%, range: 9.4%-66.2%). The median shortening rate of the SV length was 12.1% (range: 4.0%-28.0%). Factors associated with a higher shortening rate include clinical T3b-T4 stage, locally advanced tumor, and MRI detectable invasion. For SVs with and without MR detectable invasions, the length shortening was 16.7±4.8% and 11.1±4.4% (P<0.001); for the 12 invaded SVs and the invasions within, the volume reduction was 41.0±16.0% and 66.3±14.4% (P<0.001), both indicating that reduction rate of the invaded portion was higher or at least not lower than that of the normal portion of the SV. Volume of SV showed an evident reduction after a median of 5 months’ NHT (median: 39.9%, range: 9.4%-66.2%). The median shortening rate of the SV length was 12.1% (range: 4.0%-28.0%). Factors associated with a higher shortening rate include clinical T3b-T4 stage, locally advanced tumor, and MRI detectable invasion. For SVs with and without MR detectable invasions, the length shortening was 16.7±4.8% and 11.1±4.4% (P<0.001); for the 12 invaded SVs and the invasions within, the volume reduction was 41.0±16.0% and 66.3±14.4% (P<0.001), both indicating that reduction rate of the invaded portion was higher or at least not lower than that of the normal portion of the SV. ConclusionsAfter a certain period of NHT, both the SVs and tumor invasions within could reduce a lot. We also found that the invaded portion reduced more than the normal portion of the SV, which indicates that the microscopic invasion would reduce more than normal SV tissue and the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. After a certain period of NHT, both the SVs and tumor invasions within could reduce a lot. We also found that the invaded portion reduced more than the normal portion of the SV, which indicates that the microscopic invasion would reduce more than normal SV tissue and the SV segment included within the CTV could be reduced in intermediate- and high-risk patients.